Saudi Arabia Blood Glucose Device Market Size & Forecast 2025–2033

The Saudi Arabia Blood Glucose Device Market is entering a decade of strong expansion, driven by surging diabetes prevalence, patient-centric digital health innovations, and sweeping health reforms under the Kingdom’s Vision 2030. According to Renub Research, the market is projected to grow from US$ 143.96 million in 2024 to US$ 259.8 million by 2033, registering a CAGR of 6.78% between 2025 and 2033.

This momentum is propelled by increased adoption of self-monitoring systems, government-backed early screening initiatives, and a growing shift toward smart glucose monitoring devices like CGMs and Bluetooth-enabled glucometers.

Download Free Sample Report

Saudi Arabia Blood Glucose Device Market Overview

A blood glucose device—whether a glucometer, flash monitor, or continuous glucose monitoring (CGM) system—measures blood sugar levels to help individuals with diabetes track their condition and prevent complications such as hypoglycemia, hyperglycemia, kidney disease, and neuropathy. In Saudi Arabia, these devices have become indispensable due to rapidly rising lifestyle diseases.

Diabetes remains one of the most urgent public health challenges in the Kingdom. Increasingly sedentary lifestyles, calorie-rich diets, and obesity rates have sharply accelerated Type 2 diabetes across all age groups. The World Bank and IDF have consistently ranked Saudi Arabia among the highest globally for diabetes prevalence.

Today, blood glucose devices are widely accessible through pharmacies, online platforms, hospitals, and diabetes centers, helping both urban and rural populations access essential monitoring tools. Growing insurance coverage, tech-friendly consumers, and escalating public health awareness are also reshaping demand patterns.

Key Growth Drivers in the Saudi Arabia Blood Glucose Device Market

1. Surge in Type 2 Diabetes Prevalence

Saudi Arabia’s diabetes crisis is expanding at an alarming rate. As per IDF estimates:

4.27 million Saudis currently live with diabetes.

1.86 million remain undiagnosed, putting them at risk of complications.

The number of diabetics is projected to reach 5.6 million by 2030 and 7.5 million by 2045.

This dramatic rise is linked to lifestyle factors such as lack of exercise, increased consumption of fast food, higher rates of obesity, and aging demographics. As public awareness grows, more patients and families seek home-use glucose devices for daily monitoring.

The healthcare system is shifting toward preventive care, prompting physicians to recommend routine at-home glucose tracking to avoid emergency visits and hospitalizations. These trends strongly support sustained demand for blood glucose devices through 2033.

2. Technological Advancements and User-Friendly Devices

Saudi Arabia’s rapidly modernizing healthcare environment has embraced the newest wave of blood glucose monitoring technologies. Among the most impactful innovations:

Continuous Glucose Monitoring (CGM) devices

Bluetooth-enabled glucometers

Smartphone-integrated glucose readers

Wearable non-invasive sensors

These devices offer improved accuracy, real-time readings, trend analysis, and app-based analytics that help patients make faster decisions about food intake, medication, and exercise.

A landmark moment occurred in August 2023, when Nemaura Medicalreceived approval from the Saudi Food and Drug Authority (SFDA) for sugarBEAT, its non-invasive wearable glucose sensor. Recognized as a Class IIb CE-marked device, sugarBEAT provides daylong glucose pattern insights without the need for finger-prick testing.

As foreign manufacturers expand into the Kingdom and local distributors strengthen their presence, patients benefit from diverse device options, simplified interfaces, and more accurate readings—driving adoption across younger tech-savvy users as well as elderly diabetics.

3. Government Programs and Public Health Campaigns

Saudi Arabia’s Vision 2030 reform strategy is transforming the healthcare system, shifting the national focus toward prevention, early detection, and digital care.

Major initiatives include:

Nationwide diabetes screening programs

Workplace health campaigns

School-based awareness programs

Insurance-backed chronic disease management

Hospital and primary-care integration of glucose monitoring tools

Additionally, the government is increasing grants, subsidies, and digital health investments to ensure broader access to essential diabetes tools.

In 2024, the Saudi Ministry of Health partnered with Ithnain to launch a digital diabetes coaching program for over 10,000 patients, aligned with Vision 2030 prescriptions for scalable, innovative chronic disease management solutions.

These coordinated efforts are significantly expanding glucose monitoring adoption across the Kingdom.

Market Challenges

1. High Cost of Advanced Devices

Despite their advantages, advanced CGMs and smart glucometers remain expensive for many consumers. High upfront costs and limited insurance coverage for premium devices restrict mass adoption, particularly among low- and middle-income households.

While test strips are relatively affordable, continuous glucose monitors and flash monitors may be cost-prohibitive without subsidies or insurance reimbursements. This pricing challenge continues to limit the scale of adoption outside major cities.

2. Limited Awareness in Rural Regions

Rural and remote regions still face:

Lower awareness of diabetes risks

Limited access to modern medical devices

Technology hesitancy or low digital literacy

Fewer diabetes clinics and specialized centers

These gaps result in inconsistent monitoring practices and continued reliance on traditional hospital visits rather than home-monitoring options.

Expanding outreach, education, and distribution networks is essential to achieving widespread adoption nationwide.

Saudi Arabia Blood Glucose Device Market by Segment

1. Test Strips

Test strips remain a fundamental component of glucose monitoring and represent one of the largest revenue segments. They are inexpensive, convenient, portable, and widely used with conventional glucometers.

Though recurring costs can accumulate for frequent users, strong import networks and availability across major pharmacy chains maintain steady demand.

2. Blood Glucose Devices for Type 2 Diabetes

With Type 2 diabetes accounting for the vast majority of diabetic cases in the Kingdom, demand for easy-to-use devices—large screens, minimal blood samples, and fast results—continues to surge.

Physicians increasingly recommend routine home monitoring for Type 2 patients to better manage complications and reduce hospitalization rates.

Distribution Channels

Hospital Pharmacies

Hospital pharmacies play a critical role in:

Supplying devices to newly diagnosed patients

Training patients on device usage

Offering subsidized or free devices for eligible individuals

Stocking specialized pediatric and geriatric devices

Government and private hospitals remain leading adopters of advanced monitoring tools.

Retail Pharmacies

Retail chains such as Al Nahdi, Al-Dawaa, and White Pharmacy dominate the consumer market. Benefits include:

Extensive product variety

Loyalty discounts

Home delivery options

Counselling by trained pharmacists

Their expansion into secondary towns and villages widens the market footprint significantly.

Regional Insights

Dhahran

Dhahran’s high-income population and strong healthcare infrastructure make it one of the fastest-growing markets for advanced technologies like CGMs and wearable sensors. High diabetes awareness and strong private healthcare presence contribute to high adoption rates.

Riyadh

As the largest city and national capital, Riyadh leads the country in blood glucose device adoption. The city has:

The highest density of diabetes centers

Broad insurance coverage

Strong consumer demand for smart medical devices

Vision 2030-backed health investments

Riyadh is expected to remain the biggest market through 2033.

Jeddah

Jeddah’s rapidly growing urban population, rising lifestyle disorders, and dynamic healthcare ecosystem fuel strong demand for all categories of glucose devices. Both local residents and expatriates contribute to a vibrant, diverse market for glucometers and CGMs.

Market Segmentation Snapshot

Product:

• Test Strips

• Lancets

• Blood Glucose Meters

Application:

• Type 1 Diabetes

• Type 2 Diabetes

• Gestational Diabetes

End User:

• Hospital Pharmacies

• Retail Pharmacies

• Online Sales

• Diabetes Clinics & Centers

Top States:

• Dhahran

• Riyadh

• Khobar

• Jeddah

• Dammam

• Others

Key Companies Covered (5-Viewpoint Analysis)

(Overview, Key Person, Recent Developments, SWOT, Revenue)

Abbott Laboratories

Medtronic

Dexcom Inc.

B. Braun Melsungen AG

DarioHealth Corp

Sanofi

Bionime Corporation

Novo Nordisk

These global and regional leaders continue to drive innovation, expanding product portfolios, and improving accessibility in the Saudi market.

Final Thoughts

Saudi Arabia is rapidly transforming into one of the Middle East’s most promising markets for blood glucose monitoring devices. Between soaring diabetes rates, technological breakthroughs, and a government committed to preventive care, the stage is set for strong, sustained growth through 2033.

As digital health tools become more affordable and Vision 2030 further optimizes healthcare infrastructure, adoption of CGMs, smart glucometers, and remote monitoring platforms will accelerate rapidly. Manufacturers who prioritize affordability, education, and local partnerships will be best positioned to capture this expanding market.

With a projected value of US$ 259.8 million by 2033, the Saudi Arabia Blood Glucose Device Market represents a critical frontier in the Kingdom’s journey toward healthier, tech-enabled future generations.